Günther Fink1, Valérie D'Acremont2, Hannah H Leslie3, Jessica Cohen3. 1. Swiss Tropical and Public Health Institute, Basel, Switzerland; Department of Epidemiology and Public Health University of Basel, Basel, Switzerland. Electronic address: guenther.fink@swisstph.ch. 2. Swiss Tropical and Public Health Institute, Basel, Switzerland; Department of Epidemiology and Public Health University of Basel, Basel, Switzerland; Centre for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland. 3. Department of Global Health and Population and Harvard TH Chan School of Public Health, Boston, MA, USA.
Abstract
BACKGROUND: Antibiotic resistance is a major threat to global health. Although detailed information about antibiotic use in high-income countries is available, little is known regarding the use of antibiotics and cumulative exposure to antibiotics in low-income and middle-income countries (LMICs). We aimed to quantify antibiotic exposure in children younger than 5 years in LMICs. METHODS: We did a cross-sectional study in sick children younger than 5 years who attended a health-care facility in eight LMICs (Haiti, Kenya, Malawi, Namibia, Nepal, Senegal, Tanzania, and Uganda) between May, 2006, and December, 2016. Demographic and Health Surveys were used to estimate the cumulative number of illnesses related to a fever or cough and the cumulative number of visits to a health-care facility because of these illnesses for each country. We also used clinical observation data from nationally representative health-care facility-based Service Provision Assessment (SPA) surveys to estimate the proportion of children who were prescribed an antibiotic during a visit to a health-care facility and the number of antibiotic prescriptions issued that were unrelated to fever or respiratory problems. By combining these estimates, and using bootstrap analysis to compute uncertainty intervals, we estimated cumulative antibiotic exposure in children from birth up to age 5 years in each LMIC. FINDINGS: From SPA surveys, we identified 22 519 clinical observations of children younger than 5 years who visited a health-care facility because of an illness between July, 2007, and December, 2016. From DHS surveys, we identified 68 826 children younger than 5 years who visited a health-care facility between May, 2006, and November, 2016. 85·4% of health-care facility visits were related to either a fever or cough. Antibiotics were prescribed to 80·5% of children diagnosed with respiratory illness, 50·1% with diarrhoea, and 28·3% with malaria. The mean number of antibiotic prescriptions issued to children between birth and age 5 years across the eight LMICs was 24·5 (95% CI 22·6-26·7), ranging from 7·1 (6·3-7·9) in Senegal to 59·1 (54·1-64·6) in Uganda. INTERPRETATION: Between birth and age 5 years, children in LMICs are prescribed a remarkably high number of antibiotics. A large proportion of these prescriptions appear to be unnecessary. National and local efforts to reduce unnecessary prescription of antibiotics to children would likely improve both patient wellbeing (in terms of preventing side-effects) and reduce the global threat of antimicrobial resistance. FUNDING: None.
BACKGROUND: Antibiotic resistance is a major threat to global health. Although detailed information about antibiotic use in high-income countries is available, little is known regarding the use of antibiotics and cumulative exposure to antibiotics in low-income and middle-income countries (LMICs). We aimed to quantify antibiotic exposure in children younger than 5 years in LMICs. METHODS: We did a cross-sectional study in sick children younger than 5 years who attended a health-care facility in eight LMICs (Haiti, Kenya, Malawi, Namibia, Nepal, Senegal, Tanzania, and Uganda) between May, 2006, and December, 2016. Demographic and Health Surveys were used to estimate the cumulative number of illnesses related to a fever or cough and the cumulative number of visits to a health-care facility because of these illnesses for each country. We also used clinical observation data from nationally representative health-care facility-based Service Provision Assessment (SPA) surveys to estimate the proportion of children who were prescribed an antibiotic during a visit to a health-care facility and the number of antibiotic prescriptions issued that were unrelated to fever or respiratory problems. By combining these estimates, and using bootstrap analysis to compute uncertainty intervals, we estimated cumulative antibiotic exposure in children from birth up to age 5 years in each LMIC. FINDINGS: From SPA surveys, we identified 22 519 clinical observations of children younger than 5 years who visited a health-care facility because of an illness between July, 2007, and December, 2016. From DHS surveys, we identified 68 826 children younger than 5 years who visited a health-care facility between May, 2006, and November, 2016. 85·4% of health-care facility visits were related to either a fever or cough. Antibiotics were prescribed to 80·5% of children diagnosed with respiratory illness, 50·1% with diarrhoea, and 28·3% with malaria. The mean number of antibiotic prescriptions issued to children between birth and age 5 years across the eight LMICs was 24·5 (95% CI 22·6-26·7), ranging from 7·1 (6·3-7·9) in Senegal to 59·1 (54·1-64·6) in Uganda. INTERPRETATION: Between birth and age 5 years, children in LMICs are prescribed a remarkably high number of antibiotics. A large proportion of these prescriptions appear to be unnecessary. National and local efforts to reduce unnecessary prescription of antibiotics to children would likely improve both patient wellbeing (in terms of preventing side-effects) and reduce the global threat of antimicrobial resistance. FUNDING: None.
Authors: Adama M Keita; Ben J Brintz; Ashraful I Khan; Md Taufiqul Islam; Zahid Hasan Khan; Youssouf Keita; Jennifer Hwang; Eric J Nelson; Firdausi Qadri; Samba Sow; Daniel T Leung; Melissa H Watt Journal: Am J Trop Med Hyg Date: 2022-07-13 Impact factor: 3.707
Authors: Stephanie C Garbern; Tzu-Chun Chu; Monique Gainey; Samika S Kanekar; Sabiha Nasrin; Kexin Qu; Meagan A Barry; Eric J Nelson; Daniel T Leung; Christopher H Schmid; Nur H Alam; Adam C Levine Journal: Trop Med Health Date: 2021-05-10
Authors: Maya L Nadimpalli; Claire D Bourke; Ruairi C Robertson; Elisabeth Delarocque-Astagneau; Amee R Manges; Amy J Pickering Journal: BMC Med Date: 2020-12-15 Impact factor: 8.775
Authors: Joseph Paul Hicks; Sophia M Latham; Rumana Huque; Mahua Das; Jane Newell; S M Abdullah; Zunayed Al Azdi; Ishrat Jahan; Christian Rassi; Prudence Hamade; Muhammad Shafique; Mohammad Saiful Islam; Rebecca King Journal: BMC Public Health Date: 2021-02-25 Impact factor: 3.295
Authors: Nga T T Do; Huong T L Vu; Chuc T K Nguyen; Sureeporn Punpuing; Wasif Ali Khan; Margaret Gyapong; Kwaku Poku Asante; Khatia Munguambe; F Xavier Gómez-Olivé; Johannes John-Langba; Toan K Tran; Malee Sunpuwan; Esperanca Sevene; Hanh H Nguyen; Phuc D Ho; Mohammad Abdul Matin; Sabeena Ahmed; Mohammad Mahbubul Karim; Olga Cambaco; Samuel Afari-Asiedu; Ellen Boamah-Kaali; Martha Ali Abdulai; John Williams; Sabina Asiamah; Georgina Amankwah; Mary Pomaa Agyekum; Fezile Wagner; Proochista Ariana; Betuel Sigauque; Stephen Tollman; H Rogier van Doorn; Osman Sankoh; John Kinsman; Heiman F L Wertheim Journal: Lancet Glob Health Date: 2021-03-10 Impact factor: 26.763
Authors: Timothy Howarth; Raelene Brunette; Tanya Davies; Ross M Andrews; Bhavini K Patel; Steven Tong; Federica Barzi; Therese M Kearns Journal: PLoS One Date: 2020-04-17 Impact factor: 3.240